cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.7284/101490
title: ADCP (Acoustic Doppler Current Profiler) data collected during research cruise AT15-48 using a Hawaii UHDAS instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.6084/m9.figshare.7718630.v1
title: Figure S2

description: Time series of water depth, cross-shore tidal current velocity (<i>V</i><sub>c</sub>), and alongshore tidal current velocity (<i>V</i><sub>l</sub>) measured at station A (for velocities, “+” denotes the flood (southward and landward) directions, and ‘’–“denotes the ebb (northward and seaward) directions).made by OriginPro 2016
DOI: 10.6084/m9.figshare.7718615
title: Geochemistry of uranium mill tailings in the Athabasca Basin, Saskatchewan, Canada: A review

description: The Athabasca Basin, located in northern Saskatchewan, Canada, is a major source of global U and an important economic driver for the province and country. Athabasca Basin U deposits consist of uraninite and pitchblende dominated by quartz and aluminosilicates and varying amounts of sulfide and arsenide minerals associated with varying concentrations of As, Se, Mo, Ni, and <sup>226</sup>Ra (elements of concern; EOCs). Processing these U ores results in tailings that are often enriched in EOCs. Mill treatment processes are designed to generate tailings that minimize the long-term environmental impact of U tailings, although many challenges exist in reaching this goal. Many studies have contributed to our understanding of the geochemistry of these tailings and EOCs and their potential impact on the surrounding hydrosphere. Using nearly two decades of data from tailings samples, mill sampling campaigns, and laboratory experiments, this review provides a comprehensive analysis of the geochemistry and long-term behavior of U tailings in the Athabasca Basin and develops a geochemical model of the tailings. Results of this review are applicable to tailings generated from other milling operations with comparable acid leaching hydrometallurgical processes. This holistic review also highlights the limitations to our current understanding of U tailings geochemistry.
DOI: 10.6084/m9.figshare.7718603
title: data for Figure 5

description: Observational hydrodynamics: time series of water depth, depth-averaged velocity and SSC measured at the upper (A08, blue line), middle (M08, green line) and lower (S1/S3, red line) intertidal flat. Locations of the stations are marked in Figure 2b. <i>V</i><sub>c</sub> and <i>V</i><sub>l</sub> are the current velocity components across (offshore (ebb) “+” and onshore (flood) “−”) and along (northward (ebb) “+” and southward (flood) “−”) the intertidal flat, respectively.
DOI: 10.7284/101494
title: Multiplexed data collected during research cruise AT15-49 using a WHOI Calliope instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.6084/m9.figshare.7718597
title: Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with <sup>125</sup>I low dose rate brachytherapy for localized prostate cancer

description: <b>Background:</b> To evaluate the occurrence of erectile dysfunction at 3 years (3yED) after prostate brachytherapy (BT) and to predict 3yED after treatment based on patients and treatments characteristics. <b>Material and methods:</b> From September 2007 to July 2015, 117 men with mild or no ED [International Index of Erectile Function (IIEF-5) &gt; 16] underwent <sup>125</sup>Iodine real-time ultrasound-guided low-dose rate BT to a total dose of 160 Gy for low-risk or favorable intermediate-risk prostate adenocarcinoma, and were followed prospectively during 3 years. Median age was 63 years (51–79). The post-implant dosimetric parameters on the postoperative computer tomography were derived from the dose–volume histogram of the prostate and the penile bulb (PB), crura, neurovascular bundles (NVBs) and internal pudendal arteries (IPAs). Potential clinical confounding factors were collected. Additionally, anatomical indexes reflecting the prostate anatomical location within the pelvis were studied. These variables were compared between patients with and without 3yED. 3yED was defined as an IIEF-5 score change to the lower category between baseline, with or without medication. <b>Results:</b> The 3yED rate was 59% (62% maintained an IIEF-5 &gt; 16). On multivariate analysis, prostate D90% (<i>p</i> &gt; .5) and pretreatment characteristics including age (<i>p</i> &gt; .5), pre-implant potency (<i>p</i> &gt; .5), diabetes (<i>p</i> = .08) and high cardiovascular risk rates (<i>p</i> = .1) did not influence the occurrence of 3yED. Only the PB dose especially the D10% &gt; 51 Gy was associated with 3yED (<i>p</i> = .005). Conversely, dose to the crura, IPAs or NVBs did not seem to impact the erectile function. The prostate position, especially the apex location varied significantly between potent and impotent patients and 3yED was significantly associated with close position of the prostate apex to PB (<i>p</i> = .008). <b>Conclusion:</b> The most predictive factor of 3yED was the dose to the PB. This may be explained by variation in individual patients’ anatomy and this could allow for the development of better strategies to prevent ED.
DOI: 10.6084/m9.figshare.7718603.v1
title: data for Figure 5

description: Observational hydrodynamics: time series of water depth, depth-averaged velocity and SSC measured at the upper (A08, blue line), middle (M08, green line) and lower (S1/S3, red line) intertidal flat. Locations of the stations are marked in Figure 2b. <i>V</i><sub>c</sub> and <i>V</i><sub>l</sub> are the current velocity components across (offshore (ebb) “+” and onshore (flood) “−”) and along (northward (ebb) “+” and southward (flood) “−”) the intertidal flat, respectively.
DOI: 10.6084/m9.figshare.7718576
title: Supplementary Material for: Rectal Dieulafoy’s Lesion: A Rare Etiology of Lower Gastrointestinal Hemorrhage

description: A Dieulafoy’s lesion is defined as a dilated submucosal vessel that erodes the overlying epithelium without evidence of a primary ulcer or erosion. It is a rare cause of gastrointestinal bleeding that is difficult to identify and subsequently manage. Most commonly, they occur in the upper gastrointestinal tract, namely the stomach. A Dieulafoy’s lesion of the rectum, however, is an exceedingly rare presentation that can lead to life-threatening gastrointestinal bleeding. Our case consists of an 84-year-old man, who presented with lower gastrointestinal bleeding secondary to a Dieulafoy’s lesion of the rectum.
DOI: 10.6084/m9.figshare.7718597.v1
title: Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with <sup>125</sup>I low dose rate brachytherapy for localized prostate cancer

description: <b>Background:</b> To evaluate the occurrence of erectile dysfunction at 3 years (3yED) after prostate brachytherapy (BT) and to predict 3yED after treatment based on patients and treatments characteristics. <b>Material and methods:</b> From September 2007 to July 2015, 117 men with mild or no ED [International Index of Erectile Function (IIEF-5) &gt; 16] underwent <sup>125</sup>Iodine real-time ultrasound-guided low-dose rate BT to a total dose of 160 Gy for low-risk or favorable intermediate-risk prostate adenocarcinoma, and were followed prospectively during 3 years. Median age was 63 years (51–79). The post-implant dosimetric parameters on the postoperative computer tomography were derived from the dose–volume histogram of the prostate and the penile bulb (PB), crura, neurovascular bundles (NVBs) and internal pudendal arteries (IPAs). Potential clinical confounding factors were collected. Additionally, anatomical indexes reflecting the prostate anatomical location within the pelvis were studied. These variables were compared between patients with and without 3yED. 3yED was defined as an IIEF-5 score change to the lower category between baseline, with or without medication. <b>Results:</b> The 3yED rate was 59% (62% maintained an IIEF-5 &gt; 16). On multivariate analysis, prostate D90% (<i>p</i> &gt; .5) and pretreatment characteristics including age (<i>p</i> &gt; .5), pre-implant potency (<i>p</i> &gt; .5), diabetes (<i>p</i> = .08) and high cardiovascular risk rates (<i>p</i> = .1) did not influence the occurrence of 3yED. Only the PB dose especially the D10% &gt; 51 Gy was associated with 3yED (<i>p</i> = .005). Conversely, dose to the crura, IPAs or NVBs did not seem to impact the erectile function. The prostate position, especially the apex location varied significantly between potent and impotent patients and 3yED was significantly associated with close position of the prostate apex to PB (<i>p</i> = .008). <b>Conclusion:</b> The most predictive factor of 3yED was the dose to the PB. This may be explained by variation in individual patients’ anatomy and this could allow for the development of better strategies to prevent ED.
DOI: 10.7284/101493
title: ADCP (Acoustic Doppler Current Profiler) data collected during research cruise AT15-49 using a Hawaii UHDAS instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.6084/m9.figshare.7718549
title: Photogrammetric 3D models of tracks 5 and 6 of Lark Quarry trackway QM F10322 and of Caririchnium kyoungsookimi from South Korea

description: Photogrammetric 3D models of the in-situ trackway QM F10322 from Lark Quarry, based on photographs taken in 2013, as well as of a Caririchnium kyoungsookimi track from the Jindong Formation, South Korea. 3D models by Anthony Romilio.
DOI: 10.6084/m9.figshare.7718564
title: MECP2 and Associated Rett syndrome pathway WP3584

description: Pathway from WikiPathways WP3584-97933 - MECP2 and Associated Rett syndrome(Test pathway)<br>
DOI: 10.7284/101492
title: Multibeam Echosounder data collected during research cruise AT15-49 using a SeaBeam 2112 instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.6084/m9.figshare.7718537
title: Gene-RD-Provenance_V2

description: In this dataset we provide the second version of monogenic, rare diseases (OMIM identifier) with a known genetic cause (HGNC, Ensembl) supplemented with manually extracted provenance of both the disease and the discovery of the underlying genetic cause of the disease (PMID).
DOI: 10.6084/m9.figshare.7718564.v1
title: MECP2 and Associated Rett syndrome pathway WP3584

description: Pathway from WikiPathways WP3584-97933 - MECP2 and Associated Rett syndrome(Test pathway)<br>
DOI: 10.6084/m9.figshare.7718549.v1
title: Photogrammetric 3D models of tracks 5 and 6 of Lark Quarry trackway QM F10322 and of Caririchnium kyoungsookimi from South Korea

description: Photogrammetric 3D models of the in-situ trackway QM F10322 from Lark Quarry, based on photographs taken in 2013, as well as of a Caririchnium kyoungsookimi track from the Jindong Formation, South Korea. 3D models by Anthony Romilio.
DOI: 10.6084/m9.figshare.7718519
title: Prevalence of chronic hepatitis C virus infection among childhood cancer survivors in Stockholm, Sweden

description: <b>Background:</b> Childhood cancer survivors treated before 1992, when blood donor screening for hepatitis C virus (HCV) infection was introduced, are at risk of transfusion-transmitted HCV infection. A national HCV screening campaign targeting blood transfusion recipients was launched in Sweden in 2007–2010. The aims of this study were to, among adult childhood cancer survivors in Stockholm County, investigate the prevalence of HCV infection, the natural course of infection, treatment outcome and anti-HCV testing frequency before, during and after the screening campaign and finally to actively screen the untested ones. <b>Material and Methods:</b> This was a combined retrospective register based and prospective screening study of adult childhood cancer survivors (<i>n</i> = 686) treated for malignancy in Stockholm before 1992. In the first part, we investigated the prevalence of HCV infection and previous anti-HCV testing, and in the second part, we actively traced and HCV-screened the remaining untested cohort living in Stockholm. Analysis of previous documented anti-HCV tests in medical records, laboratory records, and the national communicable disease registry was performed. In the second part, 231 presumably untested individuals were contacted by mail and offered an anti-HCV test. The natural course of HCV infection and treatment outcome was analyzed for those found to be chronically infected. <b>Results:</b> In total, 235 patients were tested and 11 were HCV-RNA positive. The overall prevalence of chronic HCV infection among the tested childhood cancer survivors was thus 4.7% (95% CI = 2.6–8.2%), which is almost 10 times higher than the national prevalence of 0.5%. Only 12% of the Stockholm cohort were tested during the screening campaign in 2007–2010, while the test uptake using active tracing screening within this study was 40% (<i>p</i> <b>Conclusion:</b> With today’s effective treatment options, active tracing and HCV screening of childhood cancer survivors are recommended.
DOI: 10.7284/101498
title: Multiplexed data collected during research cruise AT15-51 using a WHOI Calliope instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.7284/101497
title: ADCP (Acoustic Doppler Current Profiler) data collected during research cruise AT15-51 using a Hawaii UHDAS instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.6084/m9.figshare.7718519.v2
title: Prevalence of chronic hepatitis C virus infection among childhood cancer survivors in Stockholm, Sweden

description: <b>Background:</b> Childhood cancer survivors treated before 1992, when blood donor screening for hepatitis C virus (HCV) infection was introduced, are at risk of transfusion-transmitted HCV infection. A national HCV screening campaign targeting blood transfusion recipients was launched in Sweden in 2007–2010. The aims of this study were to, among adult childhood cancer survivors in Stockholm County, investigate the prevalence of HCV infection, the natural course of infection, treatment outcome and anti-HCV testing frequency before, during and after the screening campaign and finally to actively screen the untested ones. <b>Material and Methods:</b> This was a combined retrospective register based and prospective screening study of adult childhood cancer survivors (<i>n</i> = 686) treated for malignancy in Stockholm before 1992. In the first part, we investigated the prevalence of HCV infection and previous anti-HCV testing, and in the second part, we actively traced and HCV-screened the remaining untested cohort living in Stockholm. Analysis of previous documented anti-HCV tests in medical records, laboratory records, and the national communicable disease registry was performed. In the second part, 231 presumably untested individuals were contacted by mail and offered an anti-HCV test. The natural course of HCV infection and treatment outcome was analyzed for those found to be chronically infected. <b>Results:</b> In total, 235 patients were tested and 11 were HCV-RNA positive. The overall prevalence of chronic HCV infection among the tested childhood cancer survivors was thus 4.7% (95% CI = 2.6–8.2%), which is almost 10 times higher than the national prevalence of 0.5%. Only 12% of the Stockholm cohort were tested during the screening campaign in 2007–2010, while the test uptake using active tracing screening within this study was 40% (<i>p</i> <b>Conclusion:</b> With today’s effective treatment options, active tracing and HCV screening of childhood cancer survivors are recommended.
DOI: 10.6084/m9.figshare.7718519.v1
title: Prevalence of chronic hepatitis C virus infection among childhood cancer survivors in Stockholm, Sweden

description: <b>Background:</b> Childhood cancer survivors treated before 1992, when blood donor screening for hepatitis C virus (HCV) infection was introduced, are at risk of transfusion-transmitted HCV infection. A national HCV screening campaign targeting blood transfusion recipients was launched in Sweden in 2007–2010. The aims of this study were to, among adult childhood cancer survivors in Stockholm County, investigate the prevalence of HCV infection, the natural course of infection, treatment outcome and anti-HCV testing frequency before, during and after the screening campaign and finally to actively screen the untested ones. <b>Material and Methods:</b> This was a combined retrospective register based and prospective screening study of adult childhood cancer survivors (<i>n</i> = 686) treated for malignancy in Stockholm before 1992. In the first part, we investigated the prevalence of HCV infection and previous anti-HCV testing, and in the second part, we actively traced and HCV-screened the remaining untested cohort living in Stockholm. Analysis of previous documented anti-HCV tests in medical records, laboratory records, and the national communicable disease registry was performed. In the second part, 231 presumably untested individuals were contacted by mail and offered an anti-HCV test. The natural course of HCV infection and treatment outcome was analyzed for those found to be chronically infected. <b>Results:</b> In total, 235 patients were tested and 11 were HCV-RNA positive. The overall prevalence of chronic HCV infection among the tested childhood cancer survivors was thus 4.7% (95% CI = 2.6–8.2%), which is almost 10 times higher than the national prevalence of 0.5%. Only 12% of the Stockholm cohort were tested during the screening campaign in 2007–2010, while the test uptake using active tracing screening within this study was 40% (<i>p</i> <b>Conclusion:</b> With today’s effective treatment options, active tracing and HCV screening of childhood cancer survivors are recommended.
DOI: 10.7284/101495
title: CTD (Conductivity, Temperature, Depth) data collected during research cruise AT15-51 using a Sea-Bird SBE-911+ instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.6084/m9.figshare.7718492
title: Gene-RD-Provenance_V1

description: In this dataset we provide monogenic, rare diseases (OMIM identifier) with a known genetic cause (HGNC, Ensembl) supplemented with manually extracted provenance of both the disease and the discovery of the underlying genetic cause of the disease (PMID).
DOI: 10.7284/101496
title: Multibeam Echosounder data collected during research cruise AT15-51 using a SeaBeam 2112 instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.7284/101501
title: Multiplexed data collected during research cruise AT15-52 using a WHOI Calliope instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition
DOI: 10.25392/leicester.data.7718453
title: Motion integration is anisotropic during smooth pursuit eye movements

description: Four movies showing of how motion coherence depends on the direction of smooth pursuit eye movements. We used a multiple-aperture array, with drift speeds being attributed to correspond to (100% coherence) to a single global motion direction or randomly to some proportion.<br>Participant's task is to track the black dot and discriminate between upward or downward motion of the surrounding. All movies show global motion that is a slightly downward from horizontal. The elements are low contrast(necessary for motion to cohere) and therefore may only be visible in full screen mode or close to the screen.<b></b><i></i><sub></sub><sup></sup><br><b></b><i></i><sub></sub><sup></sup><br>Movie 1: Global motion (50% coherent) opposite to the motion of the pursuit target (black dot)<br> Movie 2: Global motion (100% coherent) opposite to the motion of the pursuit target (black dot) <br>Movie 3: Global motion (50% coherent) in the direction of the pursuit target (black dot) <b></b><i></i><sub></sub><sup></sup><br>Movie 4: Global motion (100% coherent) in the direction of the the pursuit target (black dot)<br>
DOI: 10.6084/m9.figshare.7718462
title: Quantifying the impact of tissue metabolism on solute transport in feto-placental microvascular networks

description: The raw geometric data which we use is given as STL files; the capillary surfaces surfaces end in "_Vasculature.stl" (four files) and villous surfaces end in "_Villi.stl" (four files). The geometries can be previewed in 3D by clicking on the file names.<br>Fig4_nonlinear_metabolism.mph: Simulations underlying Fig 4. Coupled transport problem, no boundary layers, mesh ~315k tetrahedral elements.<br>specimen3_FL_stripped.mph & specimen3_DL_stripped.mph: Simulations for calculating flow-limited and diffusion-limited metabolic scale functions G & F, respectively. This underlies Figs. 1, 2, 3 and 7. The mesh has approx. 19.7mio tetrahedral elements and is particularly well resolved at and near the villous surface to ensure that boundary layers for strong metabolism are resolved. Each simulation (to solve for solute in metabolising tissue) ran for approximately 10h. The meshing process itself ran for several hours. We used a powerful computer (128 GB RAM, 16 core CPU). The solutions and meshes were stripped from the Comsol files to comply with figshare's 5GB file size limitation. <br>specimen3_fully_coupled.mph: Simulations for calculating fully coupled problem with linear uptake kinetics, which underlies Fig. 2 (dots). The mesh has approximately 4.1mio tetrahedral elements.<br><br>*.nb and *.xlsx: Codes and data needed to Figures 2, 3, 4 and 7. The *.nb files were created in Mathematica 11.0.1.0, relying on the numerical data contained in the Excel (*.xlsx) files <i><b>which must be in the same folder as the *.nb files</b></i>. To reproduce the figures, open a Mathematica file and then go to Evaluation -&gt; Evaluate notebook, which will run all codes automatically and assemble all figures/subfigures. When switching between *.nb files, make sure to either close Mathematica or go to Evaluation -&gt; Quit Kernel -&gt; Local.<br>Fig6_ex-vivo_uptake_fitting.zip contains a MATLAB .m script (tested on ver. R2018a) and the associated ex-vivo pO2 datasets in a tab-separated .csv. After extracting both files into the same location, run "uptake_fit.m" to estimate the tissue metabolic parameters and reproduce Figure 6.<br>
DOI: 10.6084/m9.figshare.7718447
title: Supplementary Material for: Decision-Making Skills Moderate the Relationship between Psychological and Physical Pain with Suicidal Behavior in Depressed Patients

description: Medicine
DOI: 10.7284/101500
title: ADCP (Acoustic Doppler Current Profiler) data collected during research cruise AT15-52 using a Hawaii UHDAS instrument system onboard the platform RV Atlantis

description: Original (unprocessed) data collected during a Field_expedition